KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,161,584 | -22.0% | 225,688 | 0.0% | 30.90% | -1.2% |
| Q2 2023 | $48,940,443 | +19.4% | 225,688 | 0.0% | 31.28% | +12.1% |
| Q1 2023 | $40,993,968 | -7.6% | 225,688 | 0.0% | 27.90% | -8.7% |
| Q4 2022 | $44,347,692 | -18.4% | 225,688 | -6.6% | 30.56% | -11.9% |
| Q3 2022 | $54,352,000 | +90.4% | 241,639 | +7.1% | 34.69% | +76.9% |
| Q2 2022 | $28,552,000 | -4.1% | 225,688 | -3.9% | 19.61% | +38.9% |
| Q1 2022 | $29,772,000 | -3.2% | 234,811 | 0.0% | 14.12% | +55.1% |
| Q4 2021 | $30,760,000 | +7.1% | 234,811 | 0.0% | 9.10% | -1.0% |
| Q3 2021 | $28,724,000 | +7.3% | 234,811 | 0.0% | 9.20% | +10.6% |
| Q2 2021 | $26,766,000 | – | 234,811 | – | 8.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |